John L Lamattina Ligand Pharmaceuticals Inc (LGND) insider trading activity

LGND Quotes by TradingView

John L Lamattina is Director of LIGAND PHARMACEUTICALS INC. Currently has a direct ownership of 29,515 shares of LGND, which is worth approximately $3.1 Million. The most recent transaction as insider was on Jun 14, 2024, when has been sold 1,252 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.5K
0% 3M change
4.43% 12M change
Total Value Held $3.1 Million

JOHN L LAMATTINA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2024
BUY
Grant, award, or other acquisition
-
1,252 Added 4.07%
29,515 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
1,142 Added 3.88%
28,263 Common Stock
Jun 10 2022
BUY
Grant, award, or other acquisition
-
1,004 Added 3.66%
26,402 Common Stock
Nov 16 2021
SELL
Open market or private sale
$782,593 $161.86 p/Share
4,835 Reduced 15.99%
25,398 Common Stock
Nov 16 2021
BUY
Exercise of conversion of derivative security
$156,170 $32.3 p/Share
4,835 Added 13.79%
30,233 Common Stock
Jun 04 2021
BUY
Grant, award, or other acquisition
-
630 Added 2.42%
25,398 Common Stock

Also insider at

IMNM
Immunome Inc. Healthcare
Director
JLL

John L Lamattina

Director
Emeryville, CA

Track Institutional and Insider Activities on LGND

Follow LIGAND PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LGND shares.

Notify only if

Insider Trading

Get notified when an Ligand Pharmaceuticals Inc insider buys or sells LGND shares.

Notify only if

News

Receive news related to LIGAND PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LGND